NasdaqCM - Delayed Quote USD
Advanced Biomed Inc. (ADVB)
2.0700
+0.1200
+(6.15%)
At close: May 5 at 4:00:00 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-2,413.0070
-2,126.3400
-2,963.6250
-741.4500
-473.9750
Investing Cash Flow
-35.8430
-74.1100
-263.0090
-1,083.6840
-25.4420
Financing Cash Flow
1,686.5460
1,866.8200
458.1370
6,097.1310
697.1640
End Cash Position
2,014.3180
2,607.9730
2,622.2790
4,783.8640
65.9220
Capital Expenditure
-35.8430
-74.1100
-212.5230
-1,312.1300
-25.4420
Issuance of Capital Stock
--
--
1,011.6080
6,097.1310
697.1640
Issuance of Debt
--
1,657.3200
--
--
--
Free Cash Flow
-2,448.8500
-2,200.4500
-3,176.1480
-2,053.5800
-499.4170
6/30/2021 - 3/6/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BDSX Biodesix, Inc.
0.4743
-8.44%
BIAF bioAffinity Technologies, Inc.
0.3800
-15.27%
PRPH ProPhase Labs, Inc.
0.2946
-10.92%
CHEK Check-Cap Ltd.
0.8892
+12.56%
SHC Sotera Health Company
12.92
+4.36%
NEO NeoGenomics, Inc.
7.84
+1.82%
NDRA ENDRA Life Sciences Inc.
6.34
+3.09%
WGS GeneDx Holdings Corp.
66.16
-1.59%
EXAS Exact Sciences Corporation
53.33
+3.45%
GH Guardant Health, Inc.
44.05
-5.98%